Poloxamer 188
Poloxamer 407
Non pwodwi: Poloxamer
Kalite: Poloxamer 407, Poloxamer 188
Alyas angle: Plurnic, Poloxalkol, Monolan, Superonic, Polythylene propylene glycol, Synperonic
Non chimik: α- Idwojèn- ω- Hydroxy poly (oksid etilèn) a-poly (oksid pwopilèn) b-poly (oksid etilèn) c] copolymer blòk, α- Hydro- ω- hydroxypoly (oxyethylene) poly (oxypropylène) poly- (oksietilèn) blòk copolymer
Nimewo CAS:9003-11-6
Fòmil molekilè HO (C2H4O) a (C3H6O) b (C2H4O) aH
Dispersant, emulsifyan, solubilizer, librifyan, ajan mouye.
[1] Raymond C. Rowe, Paul J. Sheskey, Marian E. Quinn, et al.Handbook of Pharmaceutical Excipients, 6yèm ed [M].UK: Pharmaceutical Press, 2009: 506-509.
Wout administrasyon: Administrasyon je, administrasyon oral, administrasyon parodontal, ak administrasyon lokal.
[1] Baz done Engredyan Inaktif Medikaman Apwouve FDA Ameriken [2010-07-02].http://db.yaozh.com/fdafuliao
Kondisyon depo: Sere nan resipyan ki fèmen.
[1] Raymond C. Rowe, Paul J. Sheskey, Marian E. Quinn, et al.Handbook of Pharmaceutical Excipients, 6yèm ed [M].UK: Pharmaceutical Press, 2009: 506-509.
Sekirite: li jeneralman konsidere kòm ki pa toksik ak ki pa enèvan.
[1] Raymond C. Rowe, Paul J. Sheskey, Marian E. Quinn, et al.Handbook of Pharmaceutical Excipients, 6yèm ed [M].UK: Pharmaceutical Press, 2009: 506-509.
Entwodiksyon konpayi:
Hebei Guanlang Biotechnology co, Ltd se youn nan dirijan manifakti ak founisè Poloxamer, kalite prensipal nou an se Poloxamer 407 ak Poloxamer 188. Nou te nan domèn sa a depi ane 2010 e deja pou plis pase 10 ane.
Hebei Guanlang Biotechnology co, Ltd fè pati Guanlang Group, ki te fonde an 2007, ki sitiye nan vil Shijiazhuang ki se kapital la nan pwovens Hebei ak sektè mwaye nan mitan Beijing Tianjin ak Hebei e li gen avantaj nan transpò pratik.Konpayi nou an se yon modèn gwo teknoloji antrepriz chimik ak Rechèch & Devlopman, pwodiksyon ak lavant. Nou gen faktori pwòp nou yo ak laboratwa, tou ofri sèvis sentèz Customized pou kliyan nou yo.
